Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations

This investigation facilitates a better understanding of inhibitor development, the critical treatment morbidity in HA patients. Furthermore, six novel mutations are reported, which would expand the mutation spectrum of the F8 gene.

Detalles Bibliográficos
Autores principales: Nasirnejad Sola, Farzaneh, Morovvati, Saeid, Sabetghadam Moghadam, Mitra, Entezari, Malihe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752620/
https://www.ncbi.nlm.nih.gov/pubmed/33363863
http://dx.doi.org/10.1002/ccr3.3294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752620/
https://www.ncbi.nlm.nih.gov/pubmed/33363863
http://dx.doi.org/10.1002/ccr3.3294

Ejemplares similares